The Leadership Team at ALX Oncology drives strategic initiatives and oversees the development of innovative therapies to combat cancer. Comprising executives from clinical development, scientific research, finance, and regulatory affairs, this team ensures alignment across all departments, guides project prioritization, and fosters collaboration to advance the company's clinical programs and optimize resource allocation for successful outcomes.
Athanasios Tsiatis
SVP, Clinical Development
Hank Stern
VP, Chemistry, Manufacturing &...
Jaume Pons
President & Chief Scientific O...
Jeanne Jew
Chief Business Officer
Michael Chang
VP, Operations
Shelly Pinto
Interim Chief Financial Office...
Sophia Randolph
Chief Medical Officer
Susan Vermeir
VP, Regulatory Affairs & Quali...
View all